It has been estimated that 25-30% of human CNM cases remain genetically unresolved (Romero, 2010; Dowling et al., 2014) and our results raise the possibility that mutations in Pln leading to increased SERCA inhibition could be involved in those cases. This evidence concerns the gene PLN and centronuclear myopathy.